Welcome to the World Federation of ADHD

In August 2008, the World Federation of ADHD (Attention Deficit Hyperactivity Disorder) and allied disorders was founded in Zurich, Switzerland. Professor Andreas Warnke, Director of the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy at the University of Würzburg, Germany, was officially nominated the first president of this non-profit organisation. Read more about the society

ADHD is a highly heritable childhood-onset psychiatric condition, which is characterized by age-inappropriate levels of the core symptoms inattention, hyperactivity and impulsivity. The disorder affects about 5 % of the children worldwide. Recent scientific studies in ADHD reveal biological underpinnings such as multiple genetic factors, ADHD-related differences in brain structure and function, as well as changes in neurotransmitter components within the basal ganglia thalamocortical neurocircuitries. Read more about ADHD

ADHD World Federation News

01 November 2017

ADHD Abstracts Review – November issue online now:

Highlighted abstracts of the month:

Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Verbeeck W, Bekkering GE, Van den Noortgate W, Kramers C.

Cochrane Database Syst Rev. 2017 Oct 2;10:CD009504.
DOI: 10.1002/14651858.CD009504.pub2. [Epub ahead of print]

Read the full abstract

Relative age within the school year and diagnosis of attention-deficit hyperactivity disorder: a nationwide population-based study.

Sayal K, Chudal R, Hinkka-Yli-Salomäki S, Joelsson P, Sourander A.

Lancet Psychiatry. 2017 Oct 9. pii: S2215-0366(17)30394-2.
DOI: 10.1016/S2215-0366(17)30394-2.

Read the full abstract

Read all abstracts of the month November